PTH and osteoporosis: The anabolic agents include teriparatide (N terminus 34 amino acid of parathyroid hormone) and newly U.S. Food and Drug Administration-approved abaloparatide (a parathyroid hormone-related protein analog) for the treatment of osteoporosis by stimulating new bone formation (10).